Clinical Trial Update: A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK [Phase 2]

View source ↗

Summary

A Phase IIb trial evaluating the safety of Zibotentan in combination with Dapagliflozin in participants with cirrhosis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Zibotentan (zibotentan)

Snippet

Sponsor: AstraZeneca | Conditions: Liver Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2026-01-20